AHA GUIDELINES Bundle (free trial)

Diagnosis and Management of Aortic Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1483260

Contents of this Issue

Navigation

Page 43 of 97

44 Treatment Table 15. Risk Factors for Abdominal Aortic Aneurysm Strong Risk Factors Additional Risk Factors Smoking history Hypertension Older age Hyperlipidemia Male sex White race Family history of abdominal aortic aneurysm Inherited vascular connective tissue disorder Atherosclerotic cardiovascular disease 6.4.1.1. BP Management in Sporadic TAA COR LOE Recommendations 1 B-NR 1. In patients with TAA and an average systolic BP (SBP) of ≥130 mm Hg or an average diastolic BP (DBP) of ≥80 mm Hg, the use of antihypertensive medications is recommended to reduce risk of cardiovascular events. 2a C-LD 2. In patients with TAA, regardless of cause and in the absence of contraindications, use of beta blockers to achieve target BP goals is reasonable. 2a C-EO 3. In patients with TAA, regardless of etiolog y and in the absence of contraindications, ARB therapy is a reasonable adjunct to beta-blocker therapy to achieve target BP goals. 6.4.1.2. Treatment of TAA With Statins COR LOE Recommendations 2a C-LD 1. In patients with TAA and imaging or clinical evidence of atherosclerosis, statin therapy at moderate or high intensity is reasonable. 2b C-LD 2. In patients with TAA who have no evidence of atherosclerosis, the use of statin therapy may be considered.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Diagnosis and Management of Aortic Disease